Assignee
ADNAGEN GMBH
DE·3 granted patents·1 pending application·0 citations·filing 2013–2016
Top patents by PatentIndex Score
4 records- 0157US9488652B2Detection of tumor stem cells and tumor cells in epithelial-mesenchymal transition in body fluids of cancer patientsADNAGEN GMBH·Filed 2013·Granted Nov 8, 2016·0 cites·13 claims
- 0243US10006090B2Method for the quantification, qualitative genetic characterization and gene expression characterization of predetermined cellsADNAGEN GMBH·Filed 2013·Granted Jun 26, 2018·0 cites·18 claims
- 0333US2017233826A1Mrna and/or protein of ercc1 isoform 3 for use in diagnosing a resistance against a therapeutic agent and method for diagnosing a resistance against a therapeutic agent using said mrna and/or proteinADNAGEN GMBH·Filed 2015·Application pending·0 cites
- 0427US11173498B2Apparatus and method for the analysis; isolation and/or enrichment of target structures in a fluid sampleADNAGEN GMBH·Filed 2016·Granted Nov 16, 2021·0 cites·12 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →